- Home
- LUNR vs KNSA Comparison
LUNR vs KNSA Comparison
Compare LUNR & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNR
- KNSA
- Stock Information
- Founded
- LUNR 2013
- KNSA 2015
- Country
- LUNR United States
- KNSA United Kingdom
- Employees
- LUNR N/A
- KNSA N/A
- Industry
- LUNR Industrial Machinery/Components
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- LUNR Industrials
- KNSA Health Care
- Exchange
- LUNR Nasdaq
- KNSA Nasdaq
- Market Cap
- LUNR 1.5B
- KNSA 1.4B
- IPO Year
- LUNR N/A
- KNSA 2018
- Fundamental
- Price
- LUNR $18.51
- KNSA $18.54
- Analyst Decision
- LUNR Strong Buy
- KNSA Strong Buy
- Analyst Count
- LUNR 5
- KNSA 5
- Target Price
- LUNR $15.80
- KNSA $36.60
- AVG Volume (30 Days)
- LUNR 16.4M
- KNSA 485.3K
- Earning Date
- LUNR 11-14-2024
- KNSA 02-26-2025
- Dividend Yield
- LUNR N/A
- KNSA N/A
- EPS Growth
- LUNR N/A
- KNSA N/A
- EPS
- LUNR N/A
- KNSA N/A
- Revenue
- LUNR $203,899,000.00
- KNSA $384,098,000.00
- Revenue This Year
- LUNR $192.10
- KNSA $60.05
- Revenue Next Year
- LUNR $60.58
- KNSA $36.74
- P/E Ratio
- LUNR N/A
- KNSA N/A
- Revenue Growth
- LUNR 134.51
- KNSA 54.41
- 52 Week Low
- LUNR $2.49
- KNSA $16.56
- 52 Week High
- LUNR $22.32
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- LUNR 56.61
- KNSA 35.62
- Support Level
- LUNR $15.86
- KNSA $17.82
- Resistance Level
- LUNR $22.32
- KNSA $19.05
- Average True Range (ATR)
- LUNR 1.90
- KNSA 0.63
- MACD
- LUNR -0.24
- KNSA -0.08
- Stochastic Oscillator
- LUNR 41.02
- KNSA 26.09
About LUNR Intuitive Machines Inc.
Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.